Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From ReCode Therapeutics
A year after COVID-19 first turned the world upside down, executives across the biopharma industry consider what 2021 holds in store. The impact of the pandemic will have profound and long-lasting implications for a sector that has been at the heart of responding to the global health challenge.
Around 100 executives highlight the hot areas to watch on the R&D front in 2021. From cancer to CNS and from regenerative medicine to real world data, expectations are high on many fronts.
- Drug Delivery
- Large Molecule
- Nanotechnology, Chips, etc.
Drug Discovery Tools